Tempus AI, Inc. $TEM Stock Sold by Torrey Growth & Income Advisors

Torrey Growth & Income Advisors lessened its stake in Tempus AI, Inc. (NASDAQ:TEM) by 41.7% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 10,427 shares of the company’s stock after selling 7,450 shares during the period. Torrey Growth & Income Advisors’ holdings in Tempus AI were worth $880,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also recently modified their holdings of the company. Guardian Partners Inc. grew its holdings in Tempus AI by 8.3% during the third quarter. Guardian Partners Inc. now owns 2,600 shares of the company’s stock worth $213,000 after acquiring an additional 200 shares during the period. Kestra Private Wealth Services LLC raised its position in Tempus AI by 1.4% during the third quarter. Kestra Private Wealth Services LLC now owns 18,685 shares of the company’s stock valued at $1,530,000 after acquiring an additional 257 shares in the last quarter. V Square Quantitative Management LLC purchased a new position in Tempus AI during the third quarter valued at approximately $27,000. ProShare Advisors LLC lifted its holdings in Tempus AI by 5.9% in the third quarter. ProShare Advisors LLC now owns 6,500 shares of the company’s stock valued at $532,000 after acquiring an additional 360 shares during the period. Finally, Cyndeo Wealth Partners LLC lifted its holdings in Tempus AI by 6.7% in the third quarter. Cyndeo Wealth Partners LLC now owns 6,412 shares of the company’s stock valued at $525,000 after acquiring an additional 400 shares during the period. Hedge funds and other institutional investors own 24.22% of the company’s stock.

Tempus AI Stock Up 11.0%

TEM opened at $84.44 on Tuesday. The company has a market cap of $15.24 billion, a PE ratio of -79.66 and a beta of 3.61. Tempus AI, Inc. has a twelve month low of $40.77 and a twelve month high of $89.09. The company has a 50-day moving average price of $71.73 and a 200 day moving average price of $57.34. The company has a quick ratio of 3.16, a current ratio of 2.61 and a debt-to-equity ratio of 2.70.

Tempus AI (NASDAQ:TEM) last posted its quarterly earnings data on Monday, November 2nd. The company reported $0.07 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.09) by $0.16. Tempus AI had a negative return on equity of 47.00% and a negative net margin of 12.54%. The company had revenue of $411.54 million for the quarter, compared to analysts’ expectations of $409.39 million. During the same period in the previous year, the firm posted ($0.46) EPS. Tempus AI’s revenue was up 23.1% compared to the same quarter last year. Sell-side analysts expect that Tempus AI, Inc. will post -1.20 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on the company. Raymond James Financial set a $80.00 price objective on Tempus AI in a research report on Wednesday, September 2nd. UBS Group assumed coverage on shares of Tempus AI in a report on Wednesday, September 9th. They set a “neutral” rating and a $70.00 target price for the company. Piper Sandler upgraded shares of Tempus AI from a “neutral” rating to an “overweight” rating and boosted their target price for the company from $56.00 to $76.00 in a research note on Tuesday, September 1st. Jefferies Financial Group raised shares of Tempus AI from an “underperform” rating to a “hold” rating and increased their price target for the stock from $35.00 to $70.00 in a report on Tuesday, November 3rd. Finally, Stifel Nicolaus dropped their price target on shares of Tempus AI from $60.00 to $50.00 and set a “hold” rating on the stock in a research report on Monday, August 3rd. Eleven equities research analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, Tempus AI presently has a consensus rating of “Hold” and a consensus target price of $79.37.

Insiders Place Their Bets

In other Tempus AI news, CEO Ryan Fukushima sold 700 shares of Tempus AI stock in a transaction dated Wednesday, September 16th. The shares were sold at an average price of $70.00, for a total transaction of $49,000.00. Following the transaction, the chief executive officer directly owned 15,874 shares of the company’s stock, valued at $1,111,180. The trade was a 4.22% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director David Epstein sold 370 shares of the company’s stock in a transaction that occurred on Monday, November 2nd. The shares were sold at an average price of $74.29, for a total value of $27,487.30. Following the completion of the transaction, the director owned 30,474 shares in the company, valued at $2,263,913.46. This represents a 1.20% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 1,237,227 shares of company stock worth $85,388,983. 24.26% of the stock is currently owned by company insiders.

Tempus AI Profile

Tempus AI is a technology company focused on applying data and artificial intelligence to healthcare, with an emphasis on precision medicine. Its platform combines clinical and molecular data to help physicians make more informed treatment decisions and support life-sciences research.

The company provides genomic sequencing and other diagnostic testing, software tools for analyzing patient data, and services that help identify clinical trial opportunities. Its work spans oncology and other areas of medicine, and it collaborates with healthcare providers and pharmaceutical and biotechnology companies.

Founded in 2015 by entrepreneur Eric Lefkofsky, Tempus is headquartered in Chicago.